136 related articles for article (PubMed ID: 10878394)
41. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system.
Thapa M; Welner RS; Pelayo R; Carr DJ
J Immunol; 2008 Jan; 180(2):1098-106. PubMed ID: 18178850
[TBL] [Abstract][Full Text] [Related]
42. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
43. Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production.
Mikloska Z; Rückholdt M; Ghadiminejad I; Dunckley H; Denis M; Cunningham AL
J Immunol; 2000 May; 164(10):5167-76. PubMed ID: 10799875
[TBL] [Abstract][Full Text] [Related]
44. CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase.
Sloan DD; Zahariadis G; Posavad CM; Pate NT; Kussick SJ; Jerome KR
J Immunol; 2003 Dec; 171(12):6733-41. PubMed ID: 14662877
[TBL] [Abstract][Full Text] [Related]
45. Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region.
Sucato G; Wald A; Wakabayashi E; Vieira J; Corey L
J Infect Dis; 1998 Apr; 177(4):1069-72. PubMed ID: 9534984
[TBL] [Abstract][Full Text] [Related]
46. Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection.
Singh R; Kumar A; Creery WD; Ruben M; Giulivi A; Diaz-Mitoma F
Clin Exp Immunol; 2003 Jul; 133(1):97-107. PubMed ID: 12823283
[TBL] [Abstract][Full Text] [Related]
47. Functional cytotoxic T cells are associated with focal lesions in the brains of SJL mice with experimental herpes simplex encephalitis.
Hudson SJ; Streilein JW
J Immunol; 1994 Jun; 152(11):5540-7. PubMed ID: 8189071
[TBL] [Abstract][Full Text] [Related]
48. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
Weekes MP; Carmichael AJ; Wills MR; Mynard K; Sissons JG
J Immunol; 1999 Jun; 162(12):7569-77. PubMed ID: 10358214
[TBL] [Abstract][Full Text] [Related]
49. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
Jennings SR
J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
[TBL] [Abstract][Full Text] [Related]
50. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response.
Annels NE; Callan MF; Tan L; Rickinson AB
J Immunol; 2000 Nov; 165(9):4831-41. PubMed ID: 11046006
[TBL] [Abstract][Full Text] [Related]
51. Tissue-Resident-Memory CD8
Peng T; Phasouk K; Sodroski CN; Sun S; Hwangbo Y; Layton ED; Jin L; Klock A; Diem K; Magaret AS; Jing L; Laing K; Li A; Huang ML; Mertens M; Johnston C; Jerome KR; Koelle DM; Wald A; Knipe DM; Corey L; Zhu J
Front Immunol; 2021; 12():735643. PubMed ID: 34552595
[TBL] [Abstract][Full Text] [Related]
52. Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition.
Ramchandani M; Selke S; Magaret A; Barnum G; Huang MW; Corey L; Wald A
Sex Transm Infect; 2018 Dec; 94(8):568-570. PubMed ID: 29175899
[TBL] [Abstract][Full Text] [Related]
53. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus.
Posavad CM; Newton JJ; Rosenthal KL
J Immunol; 1993 Nov; 151(9):4865-73. PubMed ID: 8409445
[TBL] [Abstract][Full Text] [Related]
55. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
Marten NW; Stohlman SA; Smith-Begolka W; Miller SD; Dimacali E; Yao Q; Stohl S; Goverman J; Bergmann CC
J Immunol; 1999 Apr; 162(7):3905-14. PubMed ID: 10201909
[TBL] [Abstract][Full Text] [Related]
56. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.
Schiffer JT; Abu-Raddad L; Mark KE; Zhu J; Selke S; Koelle DM; Wald A; Corey L
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18973-8. PubMed ID: 20956313
[TBL] [Abstract][Full Text] [Related]
57. Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.
Laing KJ; Magaret AS; Mueller DE; Zhao L; Johnston C; De Rosa SC; Koelle DM; Wald A; Corey L
J Clin Immunol; 2010 Sep; 30(5):703-22. PubMed ID: 20635156
[TBL] [Abstract][Full Text] [Related]
58. Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.
Diaz FM; Knipe DM
Virology; 2016 Jan; 488():61-7. PubMed ID: 26609935
[TBL] [Abstract][Full Text] [Related]
59. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
Oh JE; Lee MS; Kim YJ; Lee HK
Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
[TBL] [Abstract][Full Text] [Related]
60. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus.
Posavad CM; Newton JJ; Rosenthal KL
J Virol; 1994 Jun; 68(6):4072-4. PubMed ID: 8189546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
